Search Results - "Yagi, Katsuharu"
-
1
64Cu-DOTA-anti-CTLA-4 mAb enabled PET visualization of CTLA-4 on the T-cell infiltrating tumor tissues
Published in PloS one (2014)“…Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) targeted therapy by anti-CTLA-4 monoclonal antibody (mAb) is highly effective in cancer patients. However,…”
Get full text
Journal Article -
2
Exploration of target molecules for molecular imaging of inflammatory bowel disease
Published in Biochemical and biophysical research communications (08-07-2011)“…► 18F-FDG PET could discriminate each inflamed area of IBD model mice clearly. ► 18F-FDG PET could not discriminate the difference of pathogenic mechanism. ►…”
Get full text
Journal Article -
3
Determination of nicotine, cotinine, and related alkaloids in human urine and saliva by automated in-tube solid-phase microextraction coupled with liquid chromatography–mass spectrometry
Published in Journal of pharmaceutical and biomedical analysis (15-01-2009)“…A simple, rapid and sensitive method for the determination of nicotine, cotinine, nornicotine, anabasine, and anatabine in human urine and saliva was…”
Get full text
Journal Article -
4
Determination of anabolic steroids in human urine by automated in-tube solid-phase microextraction coupled with liquid chromatography–mass spectrometry
Published in Journal of pharmaceutical and biomedical analysis (05-09-2010)“…A simple, rapid and sensitive method was developed for determining the presence of seven anabolic steroids (boldenone, nandrolone, testosterone,…”
Get full text
Journal Article -
5
sup.64Cu-DOTA-Anti-CTLA-4 mAb Enabled PET Visualization of CTLA-4 on the T-Cell Infiltrating Tumor Tissues
Published in PloS one (03-11-2014)“…Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) targeted therapy by anti-CTLA-4 monoclonal antibody (mAb) is highly effective in cancer patients. However,…”
Get full text
Journal Article -
6
64Cu-DOTA-Anti-CTLA-4 mAb Enabled PET Visualization of CTLA-4 on the T-Cell Infiltrating Tumor Tissues: e109866
Published in PloS one (01-11-2014)“…Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) targeted therapy by anti-CTLA-4 monoclonal antibody (mAb) is highly effective in cancer patients. However,…”
Get full text
Journal Article